Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction (2011)
- Authors:
- USP affiliated authors: LACCHINI, RICCARDO - FMRP ; COLOGNA, ADAUTO JOSE - FMRP ; MARTINS, ANTONIO CARLOS PEREIRA - FMRP ; SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1038/tpj.2011.49
- Subjects: DISFUNÇÃO ERÉTIL; POLIMORFISMO; FARMACOGENÉTICA
- Language: Inglês
- Imprenta:
- Source:
- Título: The Pharmacogenomics Journal
- ISSN: 1470-269X
- Volume/Número/Paginação/Ano: v. 3, n. 3, on-line, 2011
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MUNIZ, J. J. et al. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. The Pharmacogenomics Journal, v. 3, n. 3, 2011Tradução . . Disponível em: https://doi.org/10.1038/tpj.2011.49. Acesso em: 31 dez. 2025. -
APA
Muniz, J. J., Lacchini, R., Rinaldi, T. O., Nobre, Y. T. D. A., Cologna, A. J., Martins, A. C. P., & Tanus-Santos, J. E. (2011). Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction. The Pharmacogenomics Journal, 3( 3). doi:10.1038/tpj.2011.49 -
NLM
Muniz JJ, Lacchini R, Rinaldi TO, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2025 dez. 31 ] Available from: https://doi.org/10.1038/tpj.2011.49 -
Vancouver
Muniz JJ, Lacchini R, Rinaldi TO, Nobre YTDA, Cologna AJ, Martins ACP, Tanus-Santos JE. Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction [Internet]. The Pharmacogenomics Journal. 2011 ; 3( 3):[citado 2025 dez. 31 ] Available from: https://doi.org/10.1038/tpj.2011.49 - Relationship between Arginase 1 and Arginase 2 levels and genetic polymorphisms with erectile dysfunction
- VEGF genetic polymorphisms affect the responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- Influence of arginase polymorphisms and arginase levels/activity on the response to erectile dysfunction therapy with sildenafil
- nNOS polymorphisms are associated with responsiveness to sildenafil in clinical and postoperative erectile dysfunction
- Plasma arginase activity may affect the responses to sildenafil in patients with erectile dysfunction
- Circulating matrix metalloproteinases and their endogenous inhibitors in patients with erectile dysfunction
- Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
Informações sobre o DOI: 10.1038/tpj.2011.49 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
